Biohit Oyj reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 6.1 million compared to EUR 4 million a year ago. Net income was EUR 0.9 million compared to net loss of EUR 1.1 million a year ago. Basic earnings per share from continuing operations was EUR 0.06 compared to basic loss per share from continuing operations of EUR 0.07 a year ago. Diluted earnings per share from continuing operations was EUR 0.06 compared to diluted loss per share from continuing operations of EUR 0.07 a year ago.